Mycelex Articles
BioAlliance closer to Loramyc US launch
28 April 2008
Fujisawa makes strategic drug transfers ahead of merger
28 February 2005
Losses dip at Canada's Lorus
24 January 2005
Warner-Chilcott and Schering-Plough end agreement
20 July 2000
Healthy Second-Quarter Growth For US Drug Firms
29 July 1998
Latest Wave Of US 1st Quarter Results
7 May 1998
Trend For 1997 Strong Sales Continues In USA
5 February 1998
US 3rd Quarter Results Show Strong Growth
22 October 1997
Solid Growth For US Firms Despite Strong $
24 July 1997
Bayer Opens Pharma Plant In Pakistan
11 July 1997
Bayer Views European Self-Medication Market
8 April 1997
Orphan Drug Designations In Japan
7 April 1997
UK Medicines Control Agency Report For 1995-96
19 August 1996
Bayer Completes $9.5M Venezuela Investment
12 August 1996
More Clotrimazole Uses
29 January 1996
Schering-Plough Is "Right-Sized And Flexible"
3 July 1995
Teva Moves To Cope With Increased Competition
20 March 1995
End Of Year Encouraging For US Companies
6 February 1995
Israel's Taro Outline Plans, 3rd Qtr Results
28 November 1994
ICAAC: Preclin Data On New Anti-infectives
24 October 1994
Bayer Buys Sterling OTC Business From SB
19 September 1994
Diflucan Indication Extension
18 July 1994
PAN-EUROPEAN BRANDING IN THE OTC MARKET
4 April 1994
BRAND EQUITY IN THE OTC DRUG MARKET
7 February 1994
NIZORAL TOPS SKIN DRUG LEAGUE IN 1992
10 January 1994
EFFECTS OF UK MOVES TO CURB NHS DRUG SPENDING
10 January 1994
US BIOSCIENCE'S AIDS-RELATED DRUG APPROVED
10 January 1994
Rx-TO-OTC SWITCHES IN THE USA
6 December 1993
TAROT VIT INCREASE US SALES 23%
13 September 1993
DRUG FIRMS TO WORK TOGETHER ON AIDS R&D
26 April 1993
SUCCESSFUL POM-TO-P SWITCHES IN THE UK
9 November 1992
RPSGB CANDIDATES FOR POM-TO-P SWITCHING
2 November 1992
BAYER LAUNCHES OTC IMIDAZOLE IN UK
1 June 1992
"GREAT STRIDES" FOR SCHERING-PLOUGH
18 May 1992
GOOD SALES GROWTH FOR MAJOR US COS IN 1st QTR
27 April 1992
IMIDAZOLES TO GO OTC IN UK
27 January 1992
Showing 1-42 of 42 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
